Items Tagged ‘OptumLabs’
January 6, 2022
Big data helps in understanding asthma biologic use, outcomes
According to the Centers for Disease Control and Prevention, about 25 million Americans have asthma, and that number is increasing every year. In the last 10 years, a number of new medications have become available. Collectively referred to as ‘biologics,’ these therapies are made to target very specific parts of the body and its immune […]
Tags: asthma, big data, Che Ngufor, inflammation, Jacob Maddux, Matthew Rank, Molly Jeffery, Nilay Shah, OptumLabs
November 8, 2021
Advancements in opioids research, transformations in postsurgical prescribing
In an effort to address the prescription opioid epidemic by reducing unnecessary or excess opioid prescriptions, the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery has been leading Mayo’s research on prescribing practices. Much of this work has been directed by Elizabeth B. Habermann, Ph.D., Deputy Director […]
Tags: Aakriti Carrubba, Adyr Moss, Amanda Stanton, Amit Mathur, Ansh Goyal, C. Burcin Taner, carpal tunnel syndrome, Center for the Science of Health Care Delivery, Cody Wyles, Cornelius Thiels, Cristopher Destephano, David Warner
September 28, 2021
By Advancing the Science contributor 
Andrew Limper, M.D., was the first named associate dean of Practice Transformation, in the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. During his tenure with the center, and through his leadership, Mayo Clinic streamlined practice transformative research and discovery efforts across the institution into a single, […]
Tags: Andrew Limper, artificial intelligence, basic science, Ben Pollock, biostatistics, cardiology, Center for Clinical and Translational Science, Center for the Science of Health Care Delivery, clinical trials, Curt Storlie, discovery research, electrocardiogram
September 21, 2021
Antifibrotics may extend lives for patients with IPF
Mayo Clinic researchers recently learned that patients who are taking antifibrotic drugs for idiopathic pulmonary fibrosis (IPF) have a better chance of survival after a respiratory-related hospitalization compared to patients not receiving these medications. The study, which was supported by Three Lakes Foundation, was published recently in BMC Pulmonary Medicine. Read Three Lakes news release. […]
Tags: Andrew Limper, Center for the Science of Health Care Delivery, idiopathic pulmonary fibrosis, OptumLabs
June 15, 2021
Transforming medicine for patients with respiratory diseases
The Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery provides a unique service for Mayo Clinic. Embedded in the medical practice, its objective is to transform the practice of medicine – from the inside out. Center researchers work within multidisciplinary teams to identify areas for improvement within […]
Tags: Aahd Kubbara, acute respiratory illness, Alanna Chamberlain, Andrew Limper, Ann Vu, antifungal, biomedical research, Cassie Kennedy, Center for the Science of Health Care Delivery, chronic obstructive pulmonary disease, COPD, COVID-19
March 22, 2021
Mayo Clinic Research in the news — 3/22/2021
News including Mayo Clinic research and research expertise this week covered a wide range of topics, including genetic testing to inform prescribing blood thinners and therapies for bile duct and gall bladder cancers. A number of women’s health related articles highlighted Mayo Clinic research, there were some arguments for naps, and the ever present COVID-19 […]
Tags: antiplatelet, asthma, bile duct cancer, breast cancer, COVID-19, Diego Zaquera Carvalho, Elizabeth Stewart, gall bladder cancer, gastroenterology, genetic testing, genetics, genomics
February 8, 2021
Mayo Clinic Research in the news — 2/8/2021
In the week’s news, you can find expertise from Mayo Clinic clinicians and researchers on a range of topics, including several different heart conditions, a blood test for Alzheimer’s, cancer, disparities in diabetes care, and of course COVID-19. Expertise from a Mayo Clinic International consultant is also highlighted, along with Michael Camilleri, M.D., who received […]
Tags: Alzheimer's disease, artificial intelligence, Bart Demaerschalk, blood cancer, blood disease, blood test, breast cancer, cardiology, cardiovascular disease, caregivers, Center for Digital Health, Center for the Science of Health Care Delivery
February 2, 2021
Diabetes treatment disparities widespread, room for improvement
More than 34 million people in the U.S. have diabetes, reports the Centers for Disease Control and Prevention. Of these, the vast majority have type 2, or a reduced ability of their bodies to effectively process sugar in foods into energy for life. Most people with type 2 diabetes have multiple considerations – including heart […]
Tags: Centers for Disease Control and Prevention, diabetes, health care value, health disparities, health equity, heart disease, hypoglycemia, kidney disease, medication management, OptumLabs, pharmacy, Rozalina McCoy
March 3, 2020
Research News Roundup–February 2020
Each month, we publish Mayo Clinic’s Research News Roundup. This article includes brief summaries and links to news releases from the preceding month that discuss some of our latest medical research and/or research education. It also connects readers to related resources. Read on for recent findings of Mayo Clinic Research: Florida State University and Mayo Clinic […]
Tags: Amir Lerman, artificial intelligence, biomedical research, cardiovascular disease, cardiovascular medicine, COPD, diabetes, education, Florida State University, heart disease, Mayo Clinic Proceedings, medical research education
September 20, 2019
Good news about the effectiveness of antifibrotics for IPF
In a recent study published in the American Journal of Respiratory and Critical Care, a research team led by Andrew Limper, M.D., a pulmonology and critical care physician at Mayo Clinic, evaluated the effectiveness of pirfenidone and nintedanib for patients with idiopathic pulmonary fibrosis. The researchers reported “the medications had an association with a reduced […]
Tags: Andrew Limper, Center for the Science of Health Care Delivery, clinical trials, idiopathic pulmonary fibrosis, OptumLabs